Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic

Arch Immunol Ther Exp (Warsz). 2023 Feb 21;71(1):7. doi: 10.1007/s00005-023-00673-0.

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its mechanisms have been thoroughly studied by researchers all over the world with the hope of finding answers that may aid the discovery of new treatment options or effective means of prevention. Still, over 2 years into the pandemic that is an immense burden on health care and economic systems, there seem to be more questions than answers. The character and multitude of immune responses elicited in coronavirus disease 2019 (COVID-19) vary from uncontrollable activation of the inflammatory system, causing extensive tissue damage and consequently leading to severe or even fatal disease, to mild or asymptomatic infections in the majority of patients, resulting in the unpredictability of the current pandemic. The aim of the study was to systematize the available data regarding the immune response to SARS-CoV-2, to provide some clarification among the abundance of the knowledge available. The review contains concise and current information on the most significant immune reactions to COVID-19, including components of both innate and adaptive immunity, with an additional focus on utilizing humoral and cellular responses as effective diagnostic tools. Moreover, the authors discussed the present state of knowledge on SARS-CoV-2 vaccines and their efficacy in cases of immunodeficiency.

Keywords: Cellular response; Humoral response; Immunosuppression; Innate immunity; SARS-CoV-2; Vaccinations.

Publication types

  • Review

MeSH terms

  • Adaptive Immunity
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Immunity, Innate
  • Pandemics
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines